The Enterprise Value as of December 2025 (TTM) for NextCell Pharma AB (NXTCL.ST) is 43.15M

According to NextCell Pharma AB’s latest financial reports and current stock price. The company's current Enterprise Value is 43.15M. This represents a change of -63.98% compared to the average of 119.80M of the last 4 quarters.

NextCell Pharma AB (NXTCL.ST) Historical Enterprise Value (quarterly & annually)

How has NXTCL.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of NextCell Pharma AB over the last ten years is 194.27M. The current 43.15M Enterprise Value has changed 2.12% with respect to the historical average. Over the past ten years (40 quarters), NXTCL.ST's Enterprise Value was at its highest in in the November 2020 quarter at 969.20M. The Enterprise Value was at its lowest in in the August 2017 quarter at -2974821.08.

NextCell Pharma AB (NXTCL.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NextCell Pharma AB Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NextCell Pharma AB (NXTCL.ST) Average Enterprise Value

How has NXTCL.ST Enterprise Value performed in the past?

The current Enterprise Value of NextCell Pharma AB (NXTCL.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NextCell Pharma AB (NXTCL.ST) Enterprise Value vs. Peers

How is NXTCL.ST’s Enterprise Value compared to its peers?

NextCell Pharma AB’s Enterprise Value is less than Active Biotech AB (publ) (70.03M), less than Pila Pharma AB (publ) (97.40M), less than Biovica International AB (publ) (112.52M), less than Nanologica AB (publ) (80.86M), less than Biosergen AB (84.62M), less than Sprint Bioscience AB (publ) (149.96M), less than Scandinavian ChemoTech AB (publ) (82.68M), less than Immunovia AB (publ) (60.07M), less than Iconovo AB (publ) (52.30M), greater than Spago Nanomedical AB (publ) (28.32M),

Build a custom stock screener for NextCell Pharma AB (NXTCL.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NextCell Pharma AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NextCell Pharma AB (NXTCL.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NextCell Pharma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.